Loading company…
ProvaLabs develops sensor solutions and biofunctional chips for biological model evaluation.
ProvaLabs develops sensors and biofunctional chips for evaluating biological models and supporting drug development. Its chips combine three-dimensional cell culture and microfluidic technologies. Founded in 2021 and based in Seoul, the company raised KRW 2.06 billion in pre-Series A funding in April 2026 to support commercialization and global expansion.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in